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For both cell-cell and cell-matrix interactions, the net adhe-
sive event is now known to be the product of a multitude of
individual binding interactions mediated by a variety of adhe-
sive ligands and counter-receptors. Thus, complex spatial ar-
rangements of membrane-intercalated molecules at the cell
surface interact specifically with complementary surfaces of
other cells or with the pre-assembled macromolecular com-
plexes of glycoproteins and proteoglycans that make up most
extracellular matrices. Despite this complexity, adhesion is a
specific process that is capable, for example, of promoting
directional cell migration and modulating tissue-specific gene
expression. To understand how the phenotypic effects of adhe-
sion are generated, studies of the structures and functions of the
molecules mediating adhesive recognition have been per-
formed, and these have, in recent years, provided significant
insights into the mechanisms involved.
Identification of RGD-containing cell-binding sequences in
adhesive macromolecules
Following the identification and purification of the major
glycoprotein components of extracellular matrices, rapid prog-
ress has been made in mapping the biological activities of these
molecules to particular protein domains. Thus, for example,
regions of fibronectin, laminin and the interstitial collagens that
mediate cell-binding have been isolated as proteolytic frag-
ments from their parent molecules. Most rapid progress in
identifying the minimal cell adhesive segments of these mole-
cules has been made with fibronectin, largely because it is
extremely amenable to dissection with enzymes or chemicals
under conditions that result in retention of biological activity.
By examining the adhesive activity of progressively smaller
fragments of fibronectin, one key active site in the centre of the
molecule was eventually reproduced in synthetic peptide form,
the minimal sequence of which was a tetrapeptide RGDS [1]
(Fig. 1). RGDS-containing peptides were found to support cell
adhesion directly and to act as competitive inhibitors of fi-
bronectin-mediated adhesion.
The surprising finding that such a short peptide could mediate
such a complex process as cell adhesion has nonetheless been
corroborated by a variety of further studies, First, although in
structure-function studies a number of amino acids other than S
were found to be tolerated in the fourth position of the tetrapep-
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tide, peptides containing substitutions in either of the first three
amino acids of the tetrapeptide lacked functional activity,
indicating a precise requirement for RGD and therefore that the
biological effects of the peptides were specific [2]. Second,
deletion of RGDS or mutation of RGDS to RGES in fusion
proteins expressed from cDNA clones spanning the central
cell-binding domain of fibronectin resulted in almost complete
loss of adhesive activity [3]. Third, the cloning and sequencing
of extracellular matrix molecules has revealed that most contain
RGD-type motifs. Furthermore, evidence has been presented
from the use of generic RGD peptide inhibitors to block the
adhesive function of RGD-containing molecules that in most
cases these sites are functional [41. Although non-RGD cell-
binding sites exist, it is clear that RGD represents a common
adhesive recognition motif.
Identification of adhesion receptors
The identification of the cell surface molecules acting as
functional adhesion receptors for extracellular matrix mole-
cules initially proved difficult owing to the relatively low affinity
of the interactions involved. For fibronectin, for example,
direct binding studies revealed an affinity constant of 0.8 M for
the intact molecule which is borderline for obtaining successful
binding in affinity chromatography experiments [5]. Somewhat
fortuitously, fragments of fibronectin containing the central
cell-binding domain of fibronectin were found to bind with
slightly higher affinity to intact cells and it proved possible to
use these fragments for affinity isolation. In this way, the
central cell-binding domain receptor was shown to be a dimer of
molecular weight 100 to 140 K that bound to affinity matrices in
an RGDS-sensitive manner [6]. After cloning and sequencing of
both subunits, it became clear that this fibronectin receptor was
one member of a large family of surface molecules which are
now called the integrins.
Integrins are composed of non-covalently-bound a and 13
subunits, of which there are currently 12 and 7 characterized
examples, respectively, in mammalian cells [4]. These 19 dif-
ferent subunits have been shown to assemble into 17 different
dimers, each of which exhibits a different ligand-binding spec-
ificity [4]. As shown in Figure 2, although there are examples of
integrin a subunits that can associate with more than one /3
subunit, the most convenient method of classification of a
particular dimer is according to its /3 subunit. As a generaliza-
tion, /31 integrins appear to be principal mediators of cell-
extracellular matrix adhesion, with fibronectin, laminin and
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Fig. 1. Schematic structure of the fibronectin
subunit. Fibronectin is a dimer linked by
disulfide bonds close to the COOH-termini of
its subunits. Each subunit has a similar
structure and is composed of a number of
homologous repeating modules (shown by
rectangles). These modules can be classified
into three types (shown by open, hatched and
cross-hatched shading). Fibronectin also
contains three sites for alternative mRNA
splicing (shown by solid shading). The two
cell-binding domains within fibronectin are
located between the two ED splice segments
(the central cell-binding domain) and in the
third splice segment (the ILICS). The central
cell-binding domain contains the RGDS
tetrapeptide as one key cell-binding site, while
the IIICS contains at least two sites, CSI
which does not have an RGD motif and CS5
which does (RGDV in rat and bovine
fibronectins and REDV in human fibronectin).
Quantitatively, CS1 dominates the activity of
the IIICS.
Fig. 2. Known mammalian integrin subunits
and dimer combinations. According to current
nomneclature, 12 a subunits and 7 /3 subunits
have been identified. The lines linking
particular a and /3 subunits indicate known
dimeric combinations. A detailed description
of the ligand-binding specificities of particular
integrins can be found in reference 4,
collagens as their major ligands, /32 integrins are involved in
leukocyte cell-cell adhesion and /33 integrins are related in
function to the /31 molecules, except that they appear to bind to
a different set of ligands including vitronectin, fibrinogen and
von Willebrand factor. The /34 subunit is currently unique
among integrins, both in terms of its structure and proposed
function. In contrast to all other /3 subunits, /34 has an extended
cytoplasmic domain, and this has been suggested to mediate
interactions with intermediate filaments in epithelial hemides-
mosome structures [71. At present, the /35, /36 and /37 subunits
are only known to associate with single a subunits, and the
quantitative importance of each of these molecules is difficult to
assess.
Structurally, all integrin a subunits are homologous to each
other, as are the /3 subunits; the pertinent features of each type
of subunit are shown in Figure 3. In general, both types of
subunit are composed of large extracellular domains, putative
transmembrane regions and short cytoplasmic domains. Some
a subunits are proteolytically processed at an extracellular site
close to the region of membrane intercalation into a disulfide-
linked heavy and light chain, others possess an inserted (or I)
domain close to the NH2-terminus. All a subunits, however,
possess a series of seven repeating polypeptide units, the last
three or four of which contain putative divalent cation-binding
sites homologous to the EF-hand structure identified in parval-
bumin and calmodulin. The possible significance of these sites
is discussed in more detail below. Integrin /3 subunits, with the
exception of /34, have few distinguishing features, although all
possess a series of extracellular, cysteine-rich repeats which
appear to explain the anomalous elecrophoretic behavior of
these subunits.
Non-RGD integrin-binding ligand active sites
Although RGD is now well established as an integrin recog-
nition sequence in many adhesive proteins, for others, domains
that lack RGD sequences have been shown to exhibit cell
adhesion-promoting activity and for some integrins, ligand
binding has been shown to be RGD-insensitive. Thus, it is likely
that other mechanisms of integrin-ligand binding exist. There
are currently two examples in which integrin-binding sites have
been localized within adhesion proteins to non-RGD sequences:
these are the IIICS domain of fibronectin and the y-chain of
fibrinogen.
The IIICS region of fibronectin is a 120-amino acid-long, cell
type-specific adhesive domain recognized by neural crest de-
rivatives and mononuclear leukocytes. Two active sites have
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Fig. 3. Integrin subunit structures. With the exception of /34, all
integrin subunits have short cytoplasmic and long extracellular do-
mains. Sites of proteolytic processing, I-domain insertion and intramo-
lecular disulfide bonding are shown.
been pinpointed using synthetic peptides within the IIICS;
these are represented by the 25- and 20-mer peptides CS! and
CS5 (Fig. 1). Whereas the minimal active sequence within CS5
is a tetrapeptide incorporating the RGD recognition motif, the
Cs I peptide, which has a dominant contribution to the adhesive
activity of the IIICS, does not possess an RGD sequence [8, 9].
Antibody-blocking and affinity chromatography experiments
have identified the receptor for both the CS1 and CSS active
sites as the integrin £t4f3, thus demonstrating in the case of CS1
that not all integrin-ligand interactions involve RGD [10, 11]. In
recent studies, the minimal active sequence within CS! has in
fact been narrowed down to a second tripeptide, LDV [12].
Interestingly, data suggest that RGDX and LDV may be func-
tionally equivalent; substitution of a glutamic acid residue for
the aspartate residue in either peptide causes an almost com-
plete loss of activity (demonstrating that both sequences have
an absolute dependence on their D residue) and both peptides
are able to competitively inhibit each other's function [131.
The second well-characterized, non-RGD integrin-binding
sequence is found at the extreme COOH-terminus of the y-chain
of fibrinogen. This region, which interacts directly with the inte-
grin aIIbf33 (also known as platelet glycoprotein Ilbilla), can be
represented by the dodecapeptide HHLGGAKQAGDV [14]. As
for RGD and LDV, HHLGGAKQAGDV activity is also depen-
dent on the penultimate D residue for activity and exhibits the
same competitive inhibition of function with the active RGD site in
the s chain of fibrinogen [15].
The equivalence of function between HHLGGAKQAGDV
and RGD and LDV and RGD suggests that each of these
sequences may be a common recognition signal employed by
adhesion proteins for integrin binding. Although no data are
available for HHLGGAKQAGDV, in preliminary studies, three
adhesion protein peptides that are homologous, but not identi-
cal, to the LDV-containing peptide CS1 have been examined for
adhesive activity. The sequences were taken from the Hepli
proteoglycan-binding domain of fibronectin (a region which is
adjacent to the IIICS and known to be recognized by a4f31) and
from two other proteins, the cytokine-inducible endothelial cell
surface protein VCAM-1 (also known to be recognized by a413)
and the lymphocyte surface antigen CD45. VCAM-l has been
implicated in leukocyte trafficking across endothelial monolay-
Fig. 4. Inte grin active sites. Currently, two regions on integrin a and /3
subunits have been proposed as ligand-binding sites. As discussed in
the text, these are the second EF-hand motif in allb and aV and a
region in the NH2-terminal half of /33.
ers, while the function of CD45 is unknown despite the strong
correlation between expression of its various isoforms and
memory cell phenotype. In all three cases, using either cell
attachment or spreading assays, peptides containing these
sequences were found to support adhesion of either lympho-
blastic leukemia or melanoma cells (Markarem, Mould and
Humphries, unpublished observations). In addition, for all
these peptides, adhesion was mediated by a4f31. Thus, prelim-
inary indications are that LDV, like RGD, may be a common
integrin-binding motif.
Hypotheses to explain integrin-ligand binding spec jficity
Despite the inherent complexities of cell adhesion outlined in
the introduction to this overview, the findings described above
indicate that there may be at least be some common molecular
basis to many of the intermolecular interactions that constitute
an adhesive event. First, the majority of data to date indicate
that adhesive ligands possess and use related aspartate-contain-
ing peptide motifs as cell-binding sites. Second, the cell surface
receptors recognizing these sequences all belong to the integrin
gene family. Thus, in the simplest case, it is conceivable that
adhesive specificity may be determined by the recognition of
particular conformations of ligand-active site peptides by struc-
turally homologous binding sites in integrin dimers. To test this
hypothesis, it is first necessary to identify the sites on integrin
receptors that interact with these sequences.
Information on the ligand-binding sites in the 133 integrins,
aVf33 and aIIb/33, has been obtained initially from chemical
cross-linking studies (Fig. 4). Using radiolabelled peptides,
RGD- and HHLGGAKQAGDV-binding sites have been found
on the alIb subunit, while a second RGD-binding site has been
localized to a region of the /33 subunit [16—19]. In the case of the
HHLGGAKQAGDV peptide, the cross-linking site was found
to be the second of the four EF-hand-type cation-binding
repeats in alib. Interestingly, the RGD cross-linking site on /33
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also shows some homology to the EF-hand consensus se-
quence, suggesting that these two types of peptide may bind
close to or at sites of divalent cation sequestration in integrins.
Although the binding sites for LDV-containing peptides have
not yet been identified, as discussed above, information from
studies of the competitiveness of peptide inhibition of cell
adhesion suggest that RGD and LDV peptides may share a
receptor-binding site on a4/31 [13]. The potential importance of
the polypeptide around the RGD cross-linking site in /33 is
enhanced by the finding that a mutation in this region of the
molecule can result in the Cam variant of Glanzmann's thromb-
asthenia [20]. This condition is a bleeding disorder character-
ized by aberrant fibrinogen-dependent platelet aggregation, and
is manifested by abnormal cation-dependent conformational
changes in aIIb/33. Similarly, a number of the mutations causing
leukocyte adhesion deficiency have been mapped to a homolo-
gous region of the /32 subunit [21]. In recent studies, a synthetic
peptide taken from the HHLGGAKQAGDV cross-linking site
on cub has been shown to block both platelet aggregation and
binding of fibrinogen to crllb/33, thus providing direct evidence
that this site is of functional relevance [22].
The presence of cation-binding sites in integrin subunits
appears to explain the dependency of integrin-ligand binding
and cell adhesion on divalent cations. Interestingly, however,
examination of the sequences of the EF-hand repeats in integrin
c subunits reveals an interesting anomaly: one of the six
residues that is normally involved in coordinating the bound
cation is absent in all integrin EF-hands. Usually this residue is
either an aspartate or a glutamate. However, in integrins it is
replaced by a small hydrophobic amino acid, This has led to the
intriguing hypothesis that the aspartate residue shown to be
critical for the functioning of the ligand motifs, RGD, LDV and
HHLGGAKQAGDV, may in fact function by providing its
side-chain for direct coordination of cation [20, 23]. Thus,
adhesive specificity may be generated by the interaction of
specific conformations of aspartate-containing active sites in
extracellular matrix proteins with particular "defective" EF-
hand structures in integrin subunits. This hypothesis could
explain the findings that multiple integrins can bind to the same
site in the same extracellular matrix molecule and that multiple
ligands can be bound by the same integrin [4]. Alternatively, the
interaction of D-containing peptides with EF-hand structures
may serve a different function in activation of integrins. There
is now considerable evidence that integrins can exist in both
low and high avidity states and that the transient activation of
the receptors is of significant physiological relevance [24]. It is
possible that initial binding of D-containing peptide sites to
EF-hands, rather than being the principal adhesive interaction,
may instead elicit conformational changes in integrins that
enhance and stabilize further ligand interactions. This hypoth-
esis is supported by the finding that soluble RGD peptides are
able to induce post-receptor binding events in csllb/33 [25].
Clearly, in addition to further peptide-based studies of ligand
and receptor active sites in adhesion molecules, one major area
of future investigation will be studies aimed at obtaining a
three-dimensional description of an integrin-ligand interaction
in order to assess the relative functional roles of aspartate-
containing peptide motifs and other cell-binding sequences.
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